1-3 of 3
Evgeny Kulesskiy, MSc
Close
Sort by
Journal Articles

Identification Of AML Subtype-Selective Drugs By Functional Ex Vivo Drug Sensitivity and Resistance Testing and Genomic Profiling

Tea Pemovska, MSc, Mika Kontro, MD, Bhagwan Yadav, MSc, Henrik Edgren, PhD, Samuli Eldfors, MSc, Agnieszka Szwajda, MSc, Henrikki Almusa, MSc, Maxim Bespalov, PhD, Pekka Ellonen, MSc, Erkki Elonen, MD, PhD, Bjorn T Gjertsen, MD PhD, Riikka Karjalainen, MSc, Evgeny Kulesskiy, MSc, Sonja Lagström, MSc, Anna Lehto, MSc, Maija Lepistö, MSc, Tuija Lundan, PhD, Muntasir Mamun Majumder, MSc, Jesus Maria Lopez Marti, PhD, Pirkko Mattila, PhD, Astrid Murumägi, PhD, Satu Mustjoki, MD, PhD, Aino Palva, MSc, Alun Parsons, MSc, Tero Pirttinen, MD, Maria E Rämet, MD, Minna Suvela, BSc, Laura Turunen, MSc, Imre Västrik, PhD, Maija Wolf, PhD, Jonathan Knowles, PhD, Tero Aittokallio, PhD, Caroline A Heckman, PhD, Kimmo Porkka, MD, PhD, Olli Kallioniemi, MD, PhD, Krister Wennerberg, PhD
Journal: Blood
Blood (2013) 122 (21): 482.
https://doi.org/10.1182/blood.V122.21.482.482
Published: 2013
Journal Articles

High-Throughput Ex Vivo Drug Sensitivity and Resistance Testing (DSRT) Integrated with Deep Genomic and Molecular Profiling Reveal New Therapy Options with Targeted Drugs in Subgroups of Relapsed Chemorefractory AML

Caroline A Heckman, PhD, Mika Kontro, MD, Tea Pemovska, MSc, Samuli Eldfors, MSc, Henrik Edgren, MSc, Evgeny Kulesskiy, MSc, Muntasir Mamun Majumder, MSc, Riikka Karjalainen, MSc, Bhagwan Yadav, MSc, Agnieszka Szwajda, MSc, Naga Poojitha Kota Venkata, MSc, Astrid Murumägi, PhD, Disha Malani, MSc, Alun Parsons, MSc, Petteri Hintsanen, PhD, Henrikki Almusa, MSc, Jesús María López Martí, PhD, Pekka Ellonen, MSc, Pirkko Mattila, PhD, Maija Lepistö, MSc, Sonja Lagström, MSc, Minna Suvela, BSc, Satu Mustjoki, MD, PhD, Janna Saarela, MD, PhD, Tero Aittokallio, PhD, Olli Kallioniemi, MD, PhD, Krister Wennerberg, PhD, Kimmo Porkka, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 288.
https://doi.org/10.1182/blood.V120.21.288.288
Published: 2012
Journal Articles

Development of a Cancer Pharmacopeia-Wide Ex-Vivo Drug Sensitivity and Resistance Testing (DSRT) Platform: Identification of MEK and mTOR As Patient-Specific Molecular Drivers of Adult AML and Potent Therapeutic Combinations with Dasatinib

Mika Kontro, MD, Caroline Heckman, PhD, Evgeny Kulesskiy, MSc, Tea Pemovska, MSc, Maxim Bespalov, PhD, Samuli Eldfors, MSc, Elonen Erkki, MD, PhD, Riikka Karjalainen, MSc, Jonathan Knowles, PhD, Disha Malani, MSc, Muntasir Mamun Majumder, MSc, John Patrick Mpindi, MSc, PhD, Astrid Murumägi, PhD, Satu Mustjoki, MD, PhD, Laura Turunen, MSc, Maija Wolf, PhD, Kimmo Porkka, MD, PhD, Krister Wennerberg, PhD, Olli Kallioniemi, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2487.
https://doi.org/10.1182/blood.V118.21.2487.2487
Published: 2011